We showed previously that murine naive CD4 + T cells and T H 1 cell clones express the beta2-adrenergic receptor (b 2 AR), while T H 2 cell clones do not. We report here that naive CD4 + T cells that differentiated for 1-5 days under T H 1 driving conditions increased b 2 AR gene expression, while cells cultured under T H 2 driving conditions decrease b 2 AR gene expression. Chromatin immunoprecipitation revealed that the increase in b 2 AR gene expression in T H 1 cells is mediated by an increase in histone 3 (H3) and H4 acetylation, as well as an increase in histone 3 lysine 4 (H3K4) methylation. Conversely, the decrease in b 2 AR gene expression in T H 2 cells is mediated by a decrease in H3 and H4 acetylation and a decrease in H3K4 methylation, as well as an increase H3K9 and H3K27 methylation. The histone changes could be detected as early as 3 days of differentiating conditions. Genomic bisulfite sequencing showed that the level of methylated CpG dinucleotides within the promoter of the b 2 AR gene was increased in T H 2 cells as compared to naive and T H 1 cells. Collectively, these results suggest that epigenetic mechanisms mediate maintenance and repression, respectively, of the b 2 AR gene expression in T H 1-and T H 2-driven cells, providing a potential mechanism by which the level of b 2 AR expression might be modulated pharmacologically within immune cells and other cell types in which the expression profile may change during a disease process.
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Introduction
Th1 cells produce interferon (IFN)-c to promote effective immune responses that protect the host against the spread of intracellular pathogens, while T H 2 cells produce interleukin (IL)-4 to promote effective immune responses that protect the host against the spread of extracellular pathogens (Abbas et al., 1996) . The development of an appropriate effector T cell response is, therefore, critical for the maintenance of homeostasis. The cellular activity of naive and effector CD4 + T cells is regulated primarily by cytokines and costimulatory molecules, as well as by neurotransmitters and hormones (Steinman, 2004) . The neurotransmitter norepinephrine is stored in sympathetic nerve terminals that reside within the parenchyma of lymphoid tissue (Kohm et al., 2000) and are in close association with CD4 + T cells (Felten et al., 1998; Felten and Olschowka, 1987) . Norepinephrine is released from these nerve terminals after antigen enters the system and binds to the beta2-adrenergic receptor (b 2 AR) that is expressed on immune cells. Engagement of the b 2 AR on an immune cell regulates cellular activity in a cAMP-and PKA-dependent manner (Kohm and Sanders, 2001) . Although it was thought that the b 2 AR was expressed on all CD4 + T cells, we now know that CD4 + T cell naive and T H 1 cells express the b 2 AR, while the T H 2 cells do not, as assessed by radioligand binding, immunofluorescence analysis, agonist-induced intracellular cAMP accumulation, and/ or reverse transcription-PCR (Ramer-Quinn et al., 1997; Sanders et al., 1997; Swanson et al., 2001) . Upon CD4 + T cell activation in the presence of a b 2 AR agonist, the level of IL-2 and IFN-c production by naive CD4 + T cells and Th1 cells changed when compared to activated, but unexposed cells, while the level of IL-4 produced by T H 2 cells remained the same (Ramer-Quinn et al., 1997; Sanders et al., 1997; Swanson et al., 2001) , supporting the pharmacologic and molecular data that a functional b 2 AR was expressed on naive and T H 1 cells, but not T H 2 cells. Thus, the collective findings suggest that an association may exist between the development of T H 1 and T H 2 cells and their ability to maintain or repress expression of the b 2 AR gene.
